Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$514M |
| 2 |
AGN
Allergan plc
AGN
|
+$364M |
| 3 |
Medtronic
MDT
|
+$323M |
| 4 |
Gilead Sciences
GILD
|
+$299M |
| 5 |
TripAdvisor
TRIP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 2 |
AGN
Allergan Inc
AGN
|
+$795M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$525M |
| 4 |
Apple
AAPL
|
+$473M |
| 5 |
Microsoft
MSFT
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.76% |
| 2 | Healthcare | 13.94% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 10.43% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
UBS Group
UBS
$176B
| $201M | 0.05% |
10,972,991
-182,338
| -2% | -$3.17M |
|
377
Lam Research
LRCX
$422B
| $201M | 0.05% |
28,619,260
-2,109,040
| -7% | -$16.7M |
|
378
Affiliated Managers Group
AMG
$9.7B
| $200M | 0.05% |
930,117
+8,459
| +0.9% | +$1.78M |
|
|
LLL
379
DELISTED
L3 Technologies, Inc.
LLL
| $199M | 0.05% |
1,585,256
-18,116
| -1% | -$2.3M |
|
380
H&R Block
HRB
$6.76B
| $199M | 0.05% |
6,193,663
-2,126,196
| -26% | -$71.2M |
|
381
Jazz Pharmaceuticals
JAZZ
$16B
| $198M | 0.05% |
1,147,661
+568,476
| +98% | +$97.6M |
|
|
CTRX
382
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $198M | 0.05% |
3,329,763
-1,531,567
| -32% | -$77.9M |
|
|
HPP
383
Hudson Pacific Properties
HPP
$787M
| $198M | 0.05% |
850,688
+284,760
| +50% | +$63.9M |
|
384
iShares Core S&P Small-Cap ETF
IJR
$113B
| $196M | 0.05% |
3,322,620
+43,668
| +1% | +$2.5M |
|
|
NVO
385
Novo Nordisk
NVO
$205B
| $196M | 0.05% |
7,336,626
-15,800
| -0.2% | -$364K |
|
386
Expedia Group
EXPE
$39.4B
| $196M | 0.05% |
2,077,958
+3,402
| +0.2% | +$302K |
|
|
STJ
387
DELISTED
St Jude Medical
STJ
| $194M | 0.05% |
2,960,787
-418,234
| -12% | -$27.8M |
|
388
Rockwell Automation
ROK
$49.5B
| $193M | 0.05% |
1,666,115
-13,989
| -0.8% | -$1.57M |
|
|
NBL
389
DELISTED
Noble Energy, Inc.
NBL
| $193M | 0.05% |
3,942,822
+203,451
| +5% | +$9.5M |
|
390
CenterPoint Energy
CNP
$26.7B
| $192M | 0.05% |
9,401,897
-1,386,515
| -13% | -$30.3M |
|
391
Alcoa
AA
$13.1B
| $190M | 0.05% |
6,120,086
+368,201
| +6% | +$13.2M |
|
392
Ulta Beauty
ULTA
$22.2B
| $190M | 0.05% |
1,256,306
-33,563
| -3% | -$4.65M |
|
393
NetApp
NTAP
$40.2B
| $189M | 0.05% |
5,321,561
-291,937
| -5% | -$11.2M |
|
|
ENDP
394
DELISTED
Endo International plc
ENDP
| $187M | 0.05% |
2,085,137
+101,674
| +5% | +$8.5M |
|
|
TCO
395
DELISTED
Taubman Centers Inc.
TCO
| $185M | 0.05% |
2,396,022
+941,318
| +65% | +$74.2M |
|
396
Weyerhaeuser
WY
$17.9B
| $184M | 0.05% |
5,542,272
-257,226
| -4% | -$9M |
|
397
Macerich
MAC
$6.99B
| $183M | 0.05% |
2,171,070
+441,338
| +26% | +$38.6M |
|
398
Labcorp
LH
$26.2B
| $183M | 0.05% |
1,685,879
+29,998
| +2% | +$3.08M |
|
399
Textron
TXT
$15.1B
| $182M | 0.05% |
4,108,262
-270,454
| -6% | -$11.8M |
|
|
SCS
400
DELISTED
Steelcase
SCS
| $182M | 0.05% |
9,589,408
+250,502
| +3% | +$4.53M |
|
Similar funds
Bank of New York Mellon's Q1 2015 Portfolio in Review
As of Q1 2015, Bank of New York Mellon held 4,377 positions worth $385B, up 0.54% from $383B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q1 2015 filing shows 128 new, 2,179 increased, 1,685 reduced and 142 closed positions. Its largest new stake was Qorvo: 1,775,142 shares worth $141M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.01B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2015 buy was Qorvo: 1,775,142 shares worth $141M.
- Bank of New York Mellon added most to Cognizant in Q1 2015, an estimated $514M increase.
- Bank of New York Mellon's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.01B.
- Bank of New York Mellon fully exited Allergan Inc in Q1 2015, selling an estimated $795M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $385B portfolio in Q1 2015.
- Bank of New York Mellon opened 128 new positions and closed 142 in Q1 2015.
- Bank of New York Mellon's portfolio value rose 0.54% quarter-over-quarter to $385B.
Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.